TE_25890
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 187.10 |
| Counts of samples | TCGA_tumor:165; TCGA_normal:0; GTEx:0 |
| TSS | chr12(+):41087022 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_25890.1 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087740,41088280,41088300 |
| teRNA_25890.2 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087740,41088280,41088314,41109882,41109902 |
| teRNA_25890.3 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087549,41087634,41087654 |
| teRNA_25890.4 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087549,41087634,41087740,41088280,41088300 |
| teRNA_25890.5 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087549,41088280,41088300 |
| teRNA_25890.6 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087371,41087740,41155511,41155531 |
| teRNA_25890.7 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087598,41087740,41088280,41088300 |
| teRNA_25890.8 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087598,41087740,41155511,41155652,41168359,41168379 |
| teRNA_25890.9 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087598,41087740,41109882,41109902 |
| teRNA_25890.10 | - | Intergenic | Non-coding | Non-coding | chr12(+):41087023,41087139,41087598,41087740,41088280,41088314,41109882,41109902 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
